A systematic search has resulted in the synthesis of a class of cytokinin antimetabolites. The development and biological properties of the anticytokinins are discussed in terms of one member of the class, 3-methyl -7 -(3 -methylbutylamino)pyrazolo [4,3 -dl-pyrimidine. way through which the cytokinin itself exerts its effect. We wish to report the discovery of a series of such compounds, the activity of which is exemplified here by one member of that series, 3-methyl-7-(3-methylbutylamino)pyrazolo [4,3-dipyrimidine (6).The distribution of cytokinins (factors promoting cell division and growth) in natural systems is widespread (1, 2) and includes compounds at the purine, ribonucleoside, ribonucleotide, and tRNA levels (3, 4). Plants presumably require cytokinins for growth, because growth of excised plant tissues is often dependent on an exogenous cytokinin supply. One cytokinin, 6-(3-methyl-2-butenylamino)purine (1) has been shown to be the active factor in the plant pathogen Corynelbacterium fascian8 (5). In addition, phytohemagglutininstimulated human lymphocyte cells are both stimulated and inhibited by 6-(3-methyl-2-butenylamino)-9-1-D-ribofuranosylpurine (2) with respect to DNA synthesis, transformation, -and mitosis (6). The-effect depended upon the stage of the cell cycle and the concentration of 2 employed. Compound 2 has antitumor activity in experimental animals (7, 8) and in preliminary clinical trials (9). In spite of this broad range of physiological activity and the occurrence of several different cytokinins in nature (1), including four as components of tRNA (10), as well as hundreds of synthetic cytokinins (1, 2), only one example of cytokinin antagonism has been reported in a compound that bears an obvious structural relationship to the known cytokinins (5). Although the structural relationship between this compound (6-methylaminopurine) and the -cytokinins suggests its potential utility in studies of the mechanism of cytokinin action, it would probably not be suitable, since it has a very slight activity as an antagonist. To date, no systematic search for compounds that would oppose the action of the cytokinins has been reported.The synthesis of a potent cytokinin antagonist is of considerable interest, since it could extend the study of cytokinins to biological systems that do not require any exogenously added cytokinins, presumably because they produce their own. The antagonist that blocks the action of the endogenous cytokinins in these systems would thus make the tissue cytokinin-dependent. The antagonist would be of greatest utility, of course, if it acted in a reversible manner on the same path- (12). In order to detect anticytokinin activity, the growth of tobacco callus was observed on a standard medium to which either 6-(3-methyl-2-butenylamino)purine or 6-benzylaminopurine had been added (over a range of concentrations) and to which the other compounds (3-6) were also added in different concentrations.
RESULTS AND DISCUSSIONThe combined effects of cytokinin and antagonist ...